Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biocon
Biotech
Biocon accused of IP theft to create cancer biotech Bicara
Bicara and its former parent company have been hit with accusations of intellectual property theft.
Fraiser Kansteiner
Oct 24, 2024 11:04am
Equillium adds 3 drugs to pipeline via $329M Bioniz buy
Feb 16, 2022 7:00am
Bicara debuts with $40M to bankroll bifunctional antibodies
Mar 15, 2021 7:00am
Ex-Genzyme CFO Sherblom joins ReForm as chair—Chutes & Ladders
Mar 5, 2021 9:30am
Mylan seeks FDA approval for biosimilar Herceptin copy
Nov 8, 2016 9:22am
Indian CRO Syngene sets up Amgen R&D center in Bangalore
Sep 6, 2016 11:13am
